Wird geladen...
QOL-58. IMPROVEMENT IN VISUAL ACUITY OF PEDIATRIC PATIENTS WITH BRAIN TUMORS WITH BEVACIZUMAB
BACKGROUND: Bevacizumab, a monoclonal antibody that targets vascular endothelial growth factor, has been shown in a small series of children with vision loss associated with optic pathway gliomas (OPG) to produce marked vision recovery. METHODS: A single-institution retrospective record review of pe...
Gespeichert in:
| Veröffentlicht in: | Neuro Oncol |
|---|---|
| Hauptverfasser: | , , , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Oxford University Press
2018
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6012326/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy059.639 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|